Association of low-frequency and rare coding-sequence variants with blood lipids and coronary heart disease in 56,000 whites and blacks
- PMID: 24507774
- PMCID: PMC3928662
- DOI: 10.1016/j.ajhg.2014.01.009
Association of low-frequency and rare coding-sequence variants with blood lipids and coronary heart disease in 56,000 whites and blacks
Abstract
Low-frequency coding DNA sequence variants in the proprotein convertase subtilisin/kexin type 9 gene (PCSK9) lower plasma low-density lipoprotein cholesterol (LDL-C), protect against risk of coronary heart disease (CHD), and have prompted the development of a new class of therapeutics. It is uncertain whether the PCSK9 example represents a paradigm or an isolated exception. We used the "Exome Array" to genotype >200,000 low-frequency and rare coding sequence variants across the genome in 56,538 individuals (42,208 European ancestry [EA] and 14,330 African ancestry [AA]) and tested these variants for association with LDL-C, high-density lipoprotein cholesterol (HDL-C), and triglycerides. Although we did not identify new genes associated with LDL-C, we did identify four low-frequency (frequencies between 0.1% and 2%) variants (ANGPTL8 rs145464906 [c.361C>T; p.Gln121*], PAFAH1B2 rs186808413 [c.482C>T; p.Ser161Leu], COL18A1 rs114139997 [c.331G>A; p.Gly111Arg], and PCSK7 rs142953140 [c.1511G>A; p.Arg504His]) with large effects on HDL-C and/or triglycerides. None of these four variants was associated with risk for CHD, suggesting that examples of low-frequency coding variants with robust effects on both lipids and CHD will be limited.
Copyright © 2014 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.
Figures
Similar articles
-
Sequence variations in PCSK9, low LDL, and protection against coronary heart disease.N Engl J Med. 2006 Mar 23;354(12):1264-72. doi: 10.1056/NEJMoa054013. N Engl J Med. 2006. PMID: 16554528
-
PCSK9 Loss-of-Function Variants, Low-Density Lipoprotein Cholesterol, and Risk of Coronary Heart Disease and Stroke: Data From 9 Studies of Blacks and Whites.Circ Cardiovasc Genet. 2017 Aug;10(4):e001632. doi: 10.1161/CIRCGENETICS.116.001632. Circ Cardiovasc Genet. 2017. PMID: 28768753 Free PMC article.
-
Comprehensive evaluation of the association of APOE genetic variation with plasma lipoprotein traits in U.S. whites and African blacks.PLoS One. 2014 Dec 12;9(12):e114618. doi: 10.1371/journal.pone.0114618. eCollection 2014. PLoS One. 2014. PMID: 25502880 Free PMC article.
-
Surprises From Genetic Analyses of Lipid Risk Factors for Atherosclerosis.Circ Res. 2016 Feb 19;118(4):579-85. doi: 10.1161/CIRCRESAHA.115.306398. Circ Res. 2016. PMID: 26892959 Free PMC article. Review.
-
Using human genetics to discover new therapeutic targets for plasma lipids.J Intern Med. 2016 Nov;280(5):487-495. doi: 10.1111/joim.12521. Epub 2016 Oct 14. J Intern Med. 2016. PMID: 27739219 Review.
Cited by
-
Functional interrogation of cellular Lp(a) uptake by genome-scale CRISPR screening.bioRxiv [Preprint]. 2024 May 12:2024.05.11.593568. doi: 10.1101/2024.05.11.593568. bioRxiv. 2024. PMID: 38766193 Free PMC article. Preprint.
-
Association of a genetic variant in angiopoietin-like 3 with serum HDL-C and risk of cardiovascular disease: A study of the MASHAD cohort over 6 years.Mol Genet Genomic Med. 2024 Apr;12(4):e2418. doi: 10.1002/mgg3.2418. Mol Genet Genomic Med. 2024. PMID: 38634215 Free PMC article.
-
Targeting host-specific metabolic pathways-opportunities and challenges for anti-infective therapy.Front Mol Biosci. 2024 Feb 22;11:1338567. doi: 10.3389/fmolb.2024.1338567. eCollection 2024. Front Mol Biosci. 2024. PMID: 38455763 Free PMC article. Review.
-
The Tehran longitudinal family-based cardiometabolic cohort study sheds new light on dyslipidemia transmission patterns.Sci Rep. 2024 Feb 27;14(1):4739. doi: 10.1038/s41598-024-53504-3. Sci Rep. 2024. PMID: 38413617 Free PMC article.
-
Variants in the CETP gene affect levels of HDL cholesterol by reducing the amount, and not the specific lipid transfer activity, of secreted CETP.PLoS One. 2023 Dec 1;18(12):e0294764. doi: 10.1371/journal.pone.0294764. eCollection 2023. PLoS One. 2023. PMID: 38039300 Free PMC article.
References
-
- Stein E.A., Mellis S., Yancopoulos G.D., Stahl N., Logan D., Smith W.B., Lisbon E., Gutierrez M., Webb C., Wu R. Effect of a monoclonal antibody to PCSK9 on LDL cholesterol. N. Engl. J. Med. 2012;366:1108–1118. - PubMed
-
- Abifadel M., Varret M., Rabès J.P., Allard D., Ouguerram K., Devillers M., Cruaud C., Benjannet S., Wickham L., Erlich D. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat. Genet. 2003;34:154–156. - PubMed
-
- Cohen J., Pertsemlidis A., Kotowski I.K., Graham R., Garcia C.K., Hobbs H.H. Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9. Nat. Genet. 2005;37:161–165. - PubMed
-
- Cohen J.C., Boerwinkle E., Mosley T.H., Jr., Hobbs H.H. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N. Engl. J. Med. 2006;354:1264–1272. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- RC2 HL102923/HL/NHLBI NIH HHS/United States
- R01 HL120393/HL/NHLBI NIH HHS/United States
- RC2 HL-102926/HL/NHLBI NIH HHS/United States
- R01HL107816/HL/NHLBI NIH HHS/United States
- HL105756/HL/NHLBI NIH HHS/United States
- RC2 HL-102923/HL/NHLBI NIH HHS/United States
- UL1 TR000124/TR/NCATS NIH HHS/United States
- R01 HL105756/HL/NHLBI NIH HHS/United States
- U01 HG006380/HG/NHGRI NIH HHS/United States
- RC2 HL-102925/HL/NHLBI NIH HHS/United States
- T32HL007208/HL/NHLBI NIH HHS/United States
- RC2 HL103010/HL/NHLBI NIH HHS/United States
- K08-HL114642/HL/NHLBI NIH HHS/United States
- MR/K026992/1/MRC_/Medical Research Council/United Kingdom
- R01 HL107816/HL/NHLBI NIH HHS/United States
- RC2 HL102926/HL/NHLBI NIH HHS/United States
- ETM/55/CSO_/Chief Scientist Office/United Kingdom
- G0700704/MRC_/Medical Research Council/United Kingdom
- T32 HL007208/HL/NHLBI NIH HHS/United States
- K08 HL114642/HL/NHLBI NIH HHS/United States
- P30 DK063491/DK/NIDDK NIH HHS/United States
- RC2 HL-102924/HL/NHLBI NIH HHS/United States
- RC2 HL102924/HL/NHLBI NIH HHS/United States
- 090532/Wellcome Trust/United Kingdom
- MC_PC_U127561128/MRC_/Medical Research Council/United Kingdom
- CZB/4/505/CSO_/Chief Scientist Office/United Kingdom
- RC2 HL-103010/HL/NHLBI NIH HHS/United States
- RC2 HL102925/HL/NHLBI NIH HHS/United States
- R21 HL121422/HL/NHLBI NIH HHS/United States
- BB/F019394/1/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous